Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.082 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |